By: Emily MacHale
Tustin, CA – Integrium, LLC announced they will be attending the 2017 BIO International Convention located in San Diego, CA on June 19-22. Integrium is looking forward to joining other industry leaders and pharmaceutical companies to fulfill networking goals and potential partnerships. As with previous years, Integrium will not only be forming relationships, but will be educating themselves on the hot topics in biotechnology, healthcare, and beyond.
BIO is home to numerous networking meetings, companies joining together to find ways to collaborate, and organizations showcasing their objectives and pipeline. With a partnering system that allows attendees to independently register and schedule their own meetings, more than 35,000+ meetings were scheduled for 2016 between 3,500 companies and in only 3.5 days, leading BIO 2017 to be one for the books. Integrium is heavily involved in the partnering system and thoroughly enjoys learning about each company’s goals and initiatives.
Integrium Executives will be taking meetings throughout BIO and encourage guests to schedule meeting requests with Mike Loftus, Executive Director of Business Development and other companies attending BIO via the BIO partnering system http://convention.bio.org/partner/. If you have trouble accessing the link please contact Mike Loftus at Mike.Loftus@integrium.com or Emily MacHale at Emily.MacHale@integrium.com.
Integrium helps Micro Cap, Small Cap, and Privately held Biotechs within the Innovator and Generic space attain clinical data so they can raise the next round of capital. Integrium’s areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases. Secondary specialties include Schedule 2 drugs and Oncology.
Check out our new website!
To learn more about Integrium, please contact:
Associate Director of Marketing & Research